BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20354440)

  • 1. Prediction of cardiovascular mortality in patients with ST-elevation myocardial infarction after primary percutaneous coronary intervention.
    Ergelen M; Gorgulu S; Uyarel H; Norgaz T; Ayhan E; Akkaya E; Soylu O; Ugur M; Tezel T
    Coron Artery Dis; 2010 Jun; 21(4):207-11. PubMed ID: 20354440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of mortality after primary percutaneous coronary intervention for acute myocardial infarction: the CADILLAC risk score.
    Halkin A; Singh M; Nikolsky E; Grines CL; Tcheng JE; Garcia E; Cox DA; Turco M; Stuckey TD; Na Y; Lansky AJ; Gersh BJ; O'Neill WW; Mehran R; Stone GW
    J Am Coll Cardiol; 2005 May; 45(9):1397-405. PubMed ID: 15862409
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early stent thrombosis in patients undergoing primary coronary stenting for acute myocardial infarction: incidence, a simple risk score, and prognosis.
    Ergelen M; Uyarel H; Osmonov D; Ayhan E; Akkaya E; Soylu O; Orhan AL; Sayar N; Bozbay M; Turer A; Yildirim E; Yekeler I
    Clin Appl Thromb Hemost; 2010 Feb; 16(1):33-41. PubMed ID: 19736213
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of outcomes in young versus nonyoung patients with ST elevation myocardial infarction treated by primary angioplasty.
    Ergelen M; Uyarel H; Gorgulu S; Norgaz T; Ayhan E; Akkaya E; Cicek G; Isik T; Gunaydin ZY; Soylu O; Uğur M; Yildirim A; Tezel T
    Coron Artery Dis; 2010 Mar; 21(2):72-7. PubMed ID: 20009922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Suboptimal coronary blood flow after primary percutaneous coronary intervention for acute myocardial infarction: incidence, a simple risk score, and prognosis.
    Uyarel H; Ayhan E; Cicek G; Isik T; Ugur M; Bozbay M; Yildirim E; Ergelen M; Eren M
    Coron Artery Dis; 2012 Mar; 23(2):98-104. PubMed ID: 22318130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mortality after emergent percutaneous coronary intervention in cardiogenic shock secondary to acute myocardial infarction and usefulness of a mortality prediction model.
    Klein LW; Shaw RE; Krone RJ; Brindis RG; Anderson HV; Block PC; McKay CR; Hewitt K; Weintraub WS;
    Am J Cardiol; 2005 Jul; 96(1):35-41. PubMed ID: 15979429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary coronary intervention in diabetic octogenarians with acute ST elevation myocardial infarction.
    Sosnowski C; Janeczko-Sosnowska E; Woźniak J; Jasiński B; Dabrowski R; Sumiński A; Wiernikowski A; Ostrzycki A; Szwed H; Ruzyłło W
    Kardiol Pol; 2007 Oct; 65(10):1181-6; discussion 1187-9. PubMed ID: 17979046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular mortality and heart failure risk score for patients after ST-segment elevation acute myocardial infarction treated with primary percutaneous coronary intervention (Data from the Leiden MISSION! Infarct Registry).
    Antoni ML; Hoogslag GE; Boden H; Liem SS; Boersma E; Fox K; Schalij MJ; Bax JJ; Delgado V
    Am J Cardiol; 2012 Jan; 109(2):187-94. PubMed ID: 22244127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting mortality in patients with ST-elevation myocardial infarction treated with primary percutaneous coronary intervention (PAMI risk score).
    Addala S; Grines CL; Dixon SR; Stone GW; Boura JA; Ochoa AB; Pellizzon G; O'Neill WW; Kahn JK
    Am J Cardiol; 2004 Mar; 93(5):629-32. PubMed ID: 14996596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A risk score to predict bleeding in patients with acute coronary syndromes.
    Mehran R; Pocock SJ; Nikolsky E; Clayton T; Dangas GD; Kirtane AJ; Parise H; Fahy M; Manoukian SV; Feit F; Ohman ME; Witzenbichler B; Guagliumi G; Lansky AJ; Stone GW
    J Am Coll Cardiol; 2010 Jun; 55(23):2556-66. PubMed ID: 20513595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Admission B-type natriuretic peptide assessment improves early risk stratification by Killip classes and TIMI risk score in patients with acute ST elevation myocardial infarction treated with primary angioplasty.
    Grabowski M; Filipiak KJ; Malek LA; Karpinski G; Huczek Z; Stolarz P; Spiewak M; Kochman J; Rudowski R; Opolski G
    Int J Cardiol; 2007 Feb; 115(3):386-90. PubMed ID: 16860415
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between electrocardiographic ST-segment resolution and early and late outcomes after primary percutaneous coronary intervention for acute myocardial infarction.
    Brodie BR; Stuckey TD; Hansen C; VerSteeg DS; Muncy DB; Moore S; Gupta N; Downey WE
    Am J Cardiol; 2005 Feb; 95(3):343-8. PubMed ID: 15670542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modalities of treatment and 30-day outcomes of unselected patients older than 75 years with acute ST-elevation myocardial infarction: data from the BLITZ study.
    De Luca L; Bolognese L; Casella G; Savonitto S; Gonzini L; Di Chiara A; De Servi S; Notaristefano S; Valagussa L; Maggioni AP; Chiarella F;
    J Cardiovasc Med (Hagerstown); 2008 Oct; 9(10):1045-51. PubMed ID: 18799968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TIMI Risk Score accurately predicts risk of death in 30-day and one-year follow-up in STEMI patients treated with primary percutaneous coronary interventions.
    Kozieradzka A; Kamiński K; Dobrzycki S; Nowak K; Musiał W
    Kardiol Pol; 2007 Jul; 65(7):788-95; discussion 796-7. PubMed ID: 17694460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the predictive value of four different risk scores for outcomes of patients with ST-elevation acute myocardial infarction undergoing primary percutaneous coronary intervention.
    Lev EI; Kornowski R; Vaknin-Assa H; Porter A; Teplitsky I; Ben-Dor I; Brosh D; Fuchs S; Battler A; Assali A
    Am J Cardiol; 2008 Jul; 102(1):6-11. PubMed ID: 18572028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprocedural hyperglycemia in ST elevation myocardial infarction submitted to percutaneous coronary intervention: a prognostic indicator and a marker of metabolic derangement.
    Lazzeri C; Chiostri M; Sori A; Valente S; Gensini GF
    J Cardiovasc Med (Hagerstown); 2010 Jan; 11(1):7-13. PubMed ID: 19829142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Should patients in cardiogenic shock undergo rescue angioplasty after failed fibrinolysis: comparison of primary versus rescue angioplasty in cardiogenic shock patients.
    Kunadian B; Vijayalakshmi K; Dunning J; Thornley AR; Sutton AG; Muir DF; Wright RA; Hall JA; de Belder MA
    J Invasive Cardiol; 2007 May; 19(5):217-23. PubMed ID: 17476036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and prognostic implications of ST-segment deviations from ambulatory Holter monitoring after ST-segment elevation myocardial infarction treated with either fibrinolysis or primary percutaneous coronary intervention (a Danish Trial in Acute Myocardial Infarction-2 Substudy).
    Idorn L; Høfsten DE; Wachtell K; Mølgaard H; Egstrup K;
    Am J Cardiol; 2007 Sep; 100(6):937-43. PubMed ID: 17826373
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of acute ST-segment elevation myocardial infarction in West Pomerania province of Poland. Comparison between primary coronary intervention and thrombolytic therapy.
    Dryja T; Kornacewicz-Jach Z; Goracy J; Przybycień K; Jodko L; Skowronek A; Kurowski M; Zinka E
    Kardiol Pol; 2006 Jun; 64(6):591-9; discussion 600-1. PubMed ID: 16810577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time to treatment and three-year mortality after primary percutaneous coronary intervention for ST-segment elevation myocardial infarction-a DANish Trial in Acute Myocardial Infarction-2 (DANAMI-2) substudy.
    Maeng M; Nielsen PH; Busk M; Mortensen LS; Kristensen SD; Nielsen TT; Andersen HR;
    Am J Cardiol; 2010 Jun; 105(11):1528-34. PubMed ID: 20494656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.